Radiopharm Theranostics revenue was $194.30k for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, RADX annual revenue was $199.5k, with -1.1% growth year-over-year.
RADX past revenue growth
How has RADX's revenue growth performed historically?
Radiopharm Theranostics (NASDAQ: RADX) reported Q2 2024 revenue of N/A up N/A year over year. In the same quarter last year, Radiopharm Theranostics's revenue was N/A.
What was Radiopharm Theranostics's revenue in 2024?
Radiopharm Theranostics's annual revenue for the twelve months ending Jun 30, 2024 was $199.49 thousand, a 1.06% decrease year over year.
How much does Radiopharm Theranostics make in a day?
Based on Radiopharm Theranostics annual revenue for the past two years, RADX makes an average of $549.47 per day.
What was Radiopharm Theranostics's annual revenue growth in the past year?
As of Q1 2025, Radiopharm Theranostics's revenue has grown -1.06% year over year. This is 1,127.38 percentage points lower than the US Biotechnology industry revenue growth rate of 1,126.32%. Radiopharm Theranostics's revenue in the past year totaled $194.30 thousand.
How much does Radiopharm Theranostics make in a year?
Radiopharm Theranostics's revenue by year for the past two years is:
Radiopharm Theranostics's revenue for the twelve months ending Jun 30, 2024 was $199.49 thousand, a 1.06% decrease year over year.
Radiopharm Theranostics's annual revenue for Jun 30, 2023 was $201.63 thousand, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.